chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dizziness, Pyrexia, Tinnitus
Clinical narrative: I also feel I have some hearing loss; Tinnitus in both ears; ear pain; I also have ear pressure; Numbness in my face and full right leg off and on; Numbness in my face and full right leg off and on; Odd sensations in the top and back of our head; 24/7 tinnitus is driving us downright mad; Odd sensations in the top and back of our head; This is a spontaneous report received a contactable consumer, the patient. This consumer reported similar events for two patients with the same product; this case is the first of two, only this case is serious. A female of unspecified age received the first dose of BNT162b2 (solution for injection; batch/lot and expiry information not provided) as a single dose via an unspecified route on an unspecified date in Mar2021 for COVID-19 immunisation. There was no medical history, concomitant or past drug history reported. The patient reported that about fifteen minutes or so after receiving the first dose of the Pfizer COVID vaccine she experienced new onset tinnitus in both ears. The patient stated that she has ear pressure, ear pain, and numbness in my face and full right leg off and on. The patient also mentioned she is experiencing odd sensations in the top and back of our head. The patient stated that she also feels she has some hearing loss though has not been able to get it checked yet. The patient exclaimed that the 24/7 tinnitus is driving her downright mad. The patient reported the she received the second dose even though she is still experiencing side effects because she wanted to do her part and get vaccinated. The outcome of the events tinnitus in both ears, ear pressure, ear pain, numbness in my face and full right leg off and on, and odd sensations on the top and back of my head, was not recovered. The outcome of the events hearing loss, and 24/7 tinnitus is driving us downright mad was unknown.   The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021465140 PFIZER (Same reporter/product, similar event in different patient)
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Arthralgia, Deafness bilateral, Ear discomfort, Ear pain, Hyperacusis
Clinical narrative: I also feel I have some hearing loss; Tinnitus in both ears; ear pain; I also have ear pressure; Numbness in my face and full right leg off and on; Numbness in my face and full right leg off and on; Odd sensations in the top and back of our head; 24/7 tinnitus is driving us downright mad; Odd sensations in the top and back of our head; This is a spontaneous report received a contactable consumer, the patient. This consumer reported similar events for two patients with the same product; this case is the first of two, only this case is serious. A female of unspecified age received the first dose of BNT162b2 (solution for injection; batch/lot and expiry information not provided) as a single dose via an unspecified route on an unspecified date in Mar2021 for COVID-19 immunisation. There was no medical history, concomitant or past drug history reported. The patient reported that about fifteen minutes or so after receiving the first dose of the Pfizer COVID vaccine she experienced new onset tinnitus in both ears. The patient stated that she has ear pressure, ear pain, and numbness in my face and full right leg off and on. The patient also mentioned she is experiencing odd sensations in the top and back of our head. The patient stated that she also feels she has some hearing loss though has not been able to get it checked yet. The patient exclaimed that the 24/7 tinnitus is driving her downright mad. The patient reported the she received the second dose even though she is still experiencing side effects because she wanted to do her part and get vaccinated. The outcome of the events tinnitus in both ears, ear pressure, ear pain, numbness in my face and full right leg off and on, and odd sensations on the top and back of my head, was not recovered. The outcome of the events hearing loss, and 24/7 tinnitus is driving us downright mad was unknown.   The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021465140 PFIZER (Same reporter/product, similar event in different patient)
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Musculoskeletal stiffness, Presyncope, Tinnitus
Clinical narrative: I also feel I have some hearing loss; Tinnitus in both ears; ear pain; I also have ear pressure; Numbness in my face and full right leg off and on; Numbness in my face and full right leg off and on; Odd sensations in the top and back of our head; 24/7 tinnitus is driving us downright mad; Odd sensations in the top and back of our head; This is a spontaneous report received a contactable consumer, the patient. This consumer reported similar events for two patients with the same product; this case is the first of two, only this case is serious. A female of unspecified age received the first dose of BNT162b2 (solution for injection; batch/lot and expiry information not provided) as a single dose via an unspecified route on an unspecified date in Mar2021 for COVID-19 immunisation. There was no medical history, concomitant or past drug history reported. The patient reported that about fifteen minutes or so after receiving the first dose of the Pfizer COVID vaccine she experienced new onset tinnitus in both ears. The patient stated that she has ear pressure, ear pain, and numbness in my face and full right leg off and on. The patient also mentioned she is experiencing odd sensations in the top and back of our head. The patient stated that she also feels she has some hearing loss though has not been able to get it checked yet. The patient exclaimed that the 24/7 tinnitus is driving her downright mad. The patient reported the she received the second dose even though she is still experiencing side effects because she wanted to do her part and get vaccinated. The outcome of the events tinnitus in both ears, ear pressure, ear pain, numbness in my face and full right leg off and on, and odd sensations on the top and back of my head, was not recovered. The outcome of the events hearing loss, and 24/7 tinnitus is driving us downright mad was unknown.   The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021465140 PFIZER (Same reporter/product, similar event in different patient)
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anger, Deafness, Ear discomfort, Ear pain, Head discomfort
Clinical narrative: I also feel I have some hearing loss; Tinnitus in both ears; ear pain; I also have ear pressure; Numbness in my face and full right leg off and on; Numbness in my face and full right leg off and on; Odd sensations in the top and back of our head; 24/7 tinnitus is driving us downright mad; Odd sensations in the top and back of our head; This is a spontaneous report received a contactable consumer, the patient. This consumer reported similar events for two patients with the same product; this case is the first of two, only this case is serious. A female of unspecified age received the first dose of BNT162b2 (solution for injection; batch/lot and expiry information not provided) as a single dose via an unspecified route on an unspecified date in Mar2021 for COVID-19 immunisation. There was no medical history, concomitant or past drug history reported. The patient reported that about fifteen minutes or so after receiving the first dose of the Pfizer COVID vaccine she experienced new onset tinnitus in both ears. The patient stated that she has ear pressure, ear pain, and numbness in my face and full right leg off and on. The patient also mentioned she is experiencing odd sensations in the top and back of our head. The patient stated that she also feels she has some hearing loss though has not been able to get it checked yet. The patient exclaimed that the 24/7 tinnitus is driving her downright mad. The patient reported the she received the second dose even though she is still experiencing side effects because she wanted to do her part and get vaccinated. The outcome of the events tinnitus in both ears, ear pressure, ear pain, numbness in my face and full right leg off and on, and odd sensations on the top and back of my head, was not recovered. The outcome of the events hearing loss, and 24/7 tinnitus is driving us downright mad was unknown.   The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021465140 PFIZER (Same reporter/product, similar event in different patient)
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Sensory disturbance, Tinnitus
Clinical narrative: I also feel I have some hearing loss; Tinnitus in both ears; ear pain; I also have ear pressure; Numbness in my face and full right leg off and on; Numbness in my face and full right leg off and on; Odd sensations in the top and back of our head; 24/7 tinnitus is driving us downright mad; Odd sensations in the top and back of our head; This is a spontaneous report received a contactable consumer, the patient. This consumer reported similar events for two patients with the same product; this case is the first of two, only this case is serious. A female of unspecified age received the first dose of BNT162b2 (solution for injection; batch/lot and expiry information not provided) as a single dose via an unspecified route on an unspecified date in Mar2021 for COVID-19 immunisation. There was no medical history, concomitant or past drug history reported. The patient reported that about fifteen minutes or so after receiving the first dose of the Pfizer COVID vaccine she experienced new onset tinnitus in both ears. The patient stated that she has ear pressure, ear pain, and numbness in my face and full right leg off and on. The patient also mentioned she is experiencing odd sensations in the top and back of our head. The patient stated that she also feels she has some hearing loss though has not been able to get it checked yet. The patient exclaimed that the 24/7 tinnitus is driving her downright mad. The patient reported the she received the second dose even though she is still experiencing side effects because she wanted to do her part and get vaccinated. The outcome of the events tinnitus in both ears, ear pressure, ear pain, numbness in my face and full right leg off and on, and odd sensations on the top and back of my head, was not recovered. The outcome of the events hearing loss, and 24/7 tinnitus is driving us downright mad was unknown.   The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021465140 PFIZER (Same reporter/product, similar event in different patient)
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: I also feel I have some hearing loss; Tinnitus in both ears; ear pain; I also have ear pressure; Numbness in my face and full right leg off and on; Numbness in my face and full right leg off and on; Odd sensations in the top and back of our head; 24/7 tinnitus is driving us downright mad; Odd sensations in the top and back of our head; This is a spontaneous report received a contactable consumer, the patient. This consumer reported similar events for two patients with the same product; this case is the first of two, only this case is serious. A female of unspecified age received the first dose of BNT162b2 (solution for injection; batch/lot and expiry information not provided) as a single dose via an unspecified route on an unspecified date in Mar2021 for COVID-19 immunisation. There was no medical history, concomitant or past drug history reported. The patient reported that about fifteen minutes or so after receiving the first dose of the Pfizer COVID vaccine she experienced new onset tinnitus in both ears. The patient stated that she has ear pressure, ear pain, and numbness in my face and full right leg off and on. The patient also mentioned she is experiencing odd sensations in the top and back of our head. The patient stated that she also feels she has some hearing loss though has not been able to get it checked yet. The patient exclaimed that the 24/7 tinnitus is driving her downright mad. The patient reported the she received the second dose even though she is still experiencing side effects because she wanted to do her part and get vaccinated. The outcome of the events tinnitus in both ears, ear pressure, ear pain, numbness in my face and full right leg off and on, and odd sensations on the top and back of my head, was not recovered. The outcome of the events hearing loss, and 24/7 tinnitus is driving us downright mad was unknown.   The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021465140 PFIZER (Same reporter/product, similar event in different patient)
Age: 59.0
Sex: F
Vaccine: UNK, UNK, COVID19
Symptoms: Anxiety, Ear discomfort, Eye pain, Headache, Sleep disorder
Clinical narrative: head pressure (specifically left ear area, also mild hearing loss left ear); Headache; head pressure (specifically left ear area, also mild hearing loss left ear); Tinnitus; loss of appetite; insomnia (still have tinnitus and ear pressure as well as insomnia); insomnia (still have tinnitus and ear pressure as well as insomnia); This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration (at the age of 59-years-old), administered in Arm Left on 23Mar2021 12:45 (Lot Number: ER8730) as single dose for COVID-19 immunization. Medical history included known allergy to penicillin. The patient was not pregnant. Not diagnosed with COVID prior vaccination. No concomitant medications received. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration (at the age of 59-years-old), administered in Arm Left on 02Mar2021 08:15 AM (Lot Number: EN6202) as single dose for COVID-19 immunization. The patient experienced headache, head pressure (specifically left ear area, also mild hearing loss left ear), tinnitus, loss of appetite, insomnia (still have tinnitus and ear pressure as well as insomnia) on 28Mar2021 12:00. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included SARS-CoV-2 test: negative on 30Mar2021. No treatment received for the events. The outcome of the events was not recovered. The event mild hearing loss left ear was considered as serious (medically significant). Facility type vaccine was Hospital. No other vaccine in four weeks.
Age: 59.0
Sex: F
Vaccine: UNK, UNK, COVID19
Symptoms: Tinnitus
Clinical narrative: head pressure (specifically left ear area, also mild hearing loss left ear); Headache; head pressure (specifically left ear area, also mild hearing loss left ear); Tinnitus; loss of appetite; insomnia (still have tinnitus and ear pressure as well as insomnia); insomnia (still have tinnitus and ear pressure as well as insomnia); This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration (at the age of 59-years-old), administered in Arm Left on 23Mar2021 12:45 (Lot Number: ER8730) as single dose for COVID-19 immunization. Medical history included known allergy to penicillin. The patient was not pregnant. Not diagnosed with COVID prior vaccination. No concomitant medications received. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration (at the age of 59-years-old), administered in Arm Left on 02Mar2021 08:15 AM (Lot Number: EN6202) as single dose for COVID-19 immunization. The patient experienced headache, head pressure (specifically left ear area, also mild hearing loss left ear), tinnitus, loss of appetite, insomnia (still have tinnitus and ear pressure as well as insomnia) on 28Mar2021 12:00. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included SARS-CoV-2 test: negative on 30Mar2021. No treatment received for the events. The outcome of the events was not recovered. The event mild hearing loss left ear was considered as serious (medically significant). Facility type vaccine was Hospital. No other vaccine in four weeks.
Age: 59.0
Sex: F
Vaccine: UNK, UNK, COVID19
Symptoms: Deafness, Decreased appetite, Ear discomfort, Head discomfort, Headache
Clinical narrative: head pressure (specifically left ear area, also mild hearing loss left ear); Headache; head pressure (specifically left ear area, also mild hearing loss left ear); Tinnitus; loss of appetite; insomnia (still have tinnitus and ear pressure as well as insomnia); insomnia (still have tinnitus and ear pressure as well as insomnia); This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration (at the age of 59-years-old), administered in Arm Left on 23Mar2021 12:45 (Lot Number: ER8730) as single dose for COVID-19 immunization. Medical history included known allergy to penicillin. The patient was not pregnant. Not diagnosed with COVID prior vaccination. No concomitant medications received. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration (at the age of 59-years-old), administered in Arm Left on 02Mar2021 08:15 AM (Lot Number: EN6202) as single dose for COVID-19 immunization. The patient experienced headache, head pressure (specifically left ear area, also mild hearing loss left ear), tinnitus, loss of appetite, insomnia (still have tinnitus and ear pressure as well as insomnia) on 28Mar2021 12:00. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included SARS-CoV-2 test: negative on 30Mar2021. No treatment received for the events. The outcome of the events was not recovered. The event mild hearing loss left ear was considered as serious (medically significant). Facility type vaccine was Hospital. No other vaccine in four weeks.
Age: 59.0
Sex: F
Vaccine: UNK, UNK, COVID19
Symptoms: Insomnia, SARS-CoV-2 test, Tinnitus
Clinical narrative: head pressure (specifically left ear area, also mild hearing loss left ear); Headache; head pressure (specifically left ear area, also mild hearing loss left ear); Tinnitus; loss of appetite; insomnia (still have tinnitus and ear pressure as well as insomnia); insomnia (still have tinnitus and ear pressure as well as insomnia); This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration (at the age of 59-years-old), administered in Arm Left on 23Mar2021 12:45 (Lot Number: ER8730) as single dose for COVID-19 immunization. Medical history included known allergy to penicillin. The patient was not pregnant. Not diagnosed with COVID prior vaccination. No concomitant medications received. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration (at the age of 59-years-old), administered in Arm Left on 02Mar2021 08:15 AM (Lot Number: EN6202) as single dose for COVID-19 immunization. The patient experienced headache, head pressure (specifically left ear area, also mild hearing loss left ear), tinnitus, loss of appetite, insomnia (still have tinnitus and ear pressure as well as insomnia) on 28Mar2021 12:00. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included SARS-CoV-2 test: negative on 30Mar2021. No treatment received for the events. The outcome of the events was not recovered. The event mild hearing loss left ear was considered as serious (medically significant). Facility type vaccine was Hospital. No other vaccine in four weeks.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests abnormal, Blood test normal, Computerised tomogram normal, Deafness unilateral, Dizziness
Clinical narrative: Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; This is a spontaneous report from a contactable consumer (patient). A 65-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 22Jan2021 10:00 (Lot Number: FL9262) as SINGLE DOSE (at age of 65 years old) for covid-19 immunisation.   Medical history included occasional migraines from an unknown date and unknown if ongoing.    The patient did not have any allergies. There were no concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19.  On 26Jan2021, the patient experienced Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist. The patient was hospitalized for 1 day on unknown date for the event "severe dizziness, tinnitus, ear pressure, deafness in left ear. after 13 weeks dizziness is lessened but still present, ear issues still persist".  The events resulted in [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Disability or permanent damage]. Therapeutic measures were taken as a result of severe dizziness, tinnitus, ear pressure, deafness in left ear. after 13 weeks dizziness is lessened but still present, ear issues still persist. Treatment included IV, Medication. The patient underwent lab tests and procedures which included nasal Swab PCR in Feb2021: result COVID negative, Blood test Antibody test in Feb2021: result COVID negative , nasal Swab PCR in Mar2021: result COVID Negative. Outcome of the events was not recovered. The patient received BNT162B2 (PFIZER) dose 2, Lot number FL9267 on 12Feb2021 10: 00am in the left arm.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram normal, Magnetic resonance imaging normal, Tinnitus, Ultrasound scan normal, Vertigo
Clinical narrative: Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; This is a spontaneous report from a contactable consumer (patient). A 65-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 22Jan2021 10:00 (Lot Number: FL9262) as SINGLE DOSE (at age of 65 years old) for covid-19 immunisation.   Medical history included occasional migraines from an unknown date and unknown if ongoing.    The patient did not have any allergies. There were no concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19.  On 26Jan2021, the patient experienced Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist. The patient was hospitalized for 1 day on unknown date for the event "severe dizziness, tinnitus, ear pressure, deafness in left ear. after 13 weeks dizziness is lessened but still present, ear issues still persist".  The events resulted in [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Disability or permanent damage]. Therapeutic measures were taken as a result of severe dizziness, tinnitus, ear pressure, deafness in left ear. after 13 weeks dizziness is lessened but still present, ear issues still persist. Treatment included IV, Medication. The patient underwent lab tests and procedures which included nasal Swab PCR in Feb2021: result COVID negative, Blood test Antibody test in Feb2021: result COVID negative , nasal Swab PCR in Mar2021: result COVID Negative. Outcome of the events was not recovered. The patient received BNT162B2 (PFIZER) dose 2, Lot number FL9267 on 12Feb2021 10: 00am in the left arm.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; This is a spontaneous report from a contactable consumer (patient). A 65-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 22Jan2021 10:00 (Lot Number: FL9262) as SINGLE DOSE (at age of 65 years old) for covid-19 immunisation.   Medical history included occasional migraines from an unknown date and unknown if ongoing.    The patient did not have any allergies. There were no concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19.  On 26Jan2021, the patient experienced Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist. The patient was hospitalized for 1 day on unknown date for the event "severe dizziness, tinnitus, ear pressure, deafness in left ear. after 13 weeks dizziness is lessened but still present, ear issues still persist".  The events resulted in [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Disability or permanent damage]. Therapeutic measures were taken as a result of severe dizziness, tinnitus, ear pressure, deafness in left ear. after 13 weeks dizziness is lessened but still present, ear issues still persist. Treatment included IV, Medication. The patient underwent lab tests and procedures which included nasal Swab PCR in Feb2021: result COVID negative, Blood test Antibody test in Feb2021: result COVID negative , nasal Swab PCR in Mar2021: result COVID Negative. Outcome of the events was not recovered. The patient received BNT162B2 (PFIZER) dose 2, Lot number FL9267 on 12Feb2021 10: 00am in the left arm.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Deafness unilateral, Dizziness, Ear discomfort, SARS-CoV-2 antibody test, SARS-CoV-2 test
Clinical narrative: Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; This is a spontaneous report from a contactable consumer (patient). A 65-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 22Jan2021 10:00 (Lot Number: FL9262) as SINGLE DOSE (at age of 65 years old) for covid-19 immunisation.   Medical history included occasional migraines from an unknown date and unknown if ongoing.    The patient did not have any allergies. There were no concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19.  On 26Jan2021, the patient experienced Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist. The patient was hospitalized for 1 day on unknown date for the event "severe dizziness, tinnitus, ear pressure, deafness in left ear. after 13 weeks dizziness is lessened but still present, ear issues still persist".  The events resulted in [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Disability or permanent damage]. Therapeutic measures were taken as a result of severe dizziness, tinnitus, ear pressure, deafness in left ear. after 13 weeks dizziness is lessened but still present, ear issues still persist. Treatment included IV, Medication. The patient underwent lab tests and procedures which included nasal Swab PCR in Feb2021: result COVID negative, Blood test Antibody test in Feb2021: result COVID negative , nasal Swab PCR in Mar2021: result COVID Negative. Outcome of the events was not recovered. The patient received BNT162B2 (PFIZER) dose 2, Lot number FL9267 on 12Feb2021 10: 00am in the left arm.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist.; This is a spontaneous report from a contactable consumer (patient). A 65-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 22Jan2021 10:00 (Lot Number: FL9262) as SINGLE DOSE (at age of 65 years old) for covid-19 immunisation.   Medical history included occasional migraines from an unknown date and unknown if ongoing.    The patient did not have any allergies. There were no concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19.  On 26Jan2021, the patient experienced Severe dizziness, tinnitus, ear pressure, deafness in left ear. After 13 weeks dizziness is lessened but still present, ear issues still persist. The patient was hospitalized for 1 day on unknown date for the event "severe dizziness, tinnitus, ear pressure, deafness in left ear. after 13 weeks dizziness is lessened but still present, ear issues still persist".  The events resulted in [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Disability or permanent damage]. Therapeutic measures were taken as a result of severe dizziness, tinnitus, ear pressure, deafness in left ear. after 13 weeks dizziness is lessened but still present, ear issues still persist. Treatment included IV, Medication. The patient underwent lab tests and procedures which included nasal Swab PCR in Feb2021: result COVID negative, Blood test Antibody test in Feb2021: result COVID negative , nasal Swab PCR in Mar2021: result COVID Negative. Outcome of the events was not recovered. The patient received BNT162B2 (PFIZER) dose 2, Lot number FL9267 on 12Feb2021 10: 00am in the left arm.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cold sweat, Computerised tomogram head normal, Condition aggravated, Decreased appetite, Dizziness
Clinical narrative: stroke symptoms; vomiting; migraine; dizziness; sleeplessness; unilateral numbness; left side numbness to her face, fingers, toes, and calf; headache; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on 30Mar2021 (Batch/Lot Number: ER8737; Expiration Date: Jul2021) as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced stroke symptoms (hospitalization, medically significant), vomiting (hospitalization), migraine (hospitalization), dizziness (hospitalization), sleeplessness (hospitalization), unilateral numbness; left side numbness to her face, fingers, toes, and calf (non-serious). On 22Apr2021, the patient experienced headache (non-serious). The clinical course was reported as follows: The patient asked if she should get the second vaccine dose after her severe side effects. The patient reported that she received her first vaccine dose on 30Mar2021 (Lot number ER8737, exp Jul2021) and experienced "pretty bad side effects afterwards." The patient reported "I was not normal for a full week", reporting that she experienced vomiting, migraines, dizziness, sleeplessness and stroke symptoms. The patient went to the hospital and the patient underwent lab tests and procedures which included magnetic resonance imaging (MRI), Computerised tomogram (CT) scan, and Electroencephalogram (EEG), for which all came back negative and she was discharged after 7 hours. The patient reported that she spoke with her health care professional (HCP) who advised her to go to the emergency room (ER) when she reported having unilateral numbness. The patient reported: left side numbness to her face, fingers, toes, and calf. The patient also reported experiencing dizziness to the point that she couldn't turn around or lean over for 4-5 days. The patient reported that the symptoms started to improve 7 days later, however, she was now apprehensive about getting the second dose.  The patient reported that her doctor said it was fine to get the second dose, but she asked if there was any additional guidance. The patient had spoken to many friends who only experienced a sore arm. On 22Apr2021, the patient woke up with a headache and threw up. The clinical outcome of the events: stroke symptoms, vomiting, migraine, dizziness, sleeplessness, unilateral numbness; left side numbness to her face, fingers, toes, and calf, was recovering. The clinical outcome of the event, headache, was unknown.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electroencephalogram normal, Feeling abnormal, Headache, Hypoaesthesia, Lethargy
Clinical narrative: stroke symptoms; vomiting; migraine; dizziness; sleeplessness; unilateral numbness; left side numbness to her face, fingers, toes, and calf; headache; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on 30Mar2021 (Batch/Lot Number: ER8737; Expiration Date: Jul2021) as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced stroke symptoms (hospitalization, medically significant), vomiting (hospitalization), migraine (hospitalization), dizziness (hospitalization), sleeplessness (hospitalization), unilateral numbness; left side numbness to her face, fingers, toes, and calf (non-serious). On 22Apr2021, the patient experienced headache (non-serious). The clinical course was reported as follows: The patient asked if she should get the second vaccine dose after her severe side effects. The patient reported that she received her first vaccine dose on 30Mar2021 (Lot number ER8737, exp Jul2021) and experienced "pretty bad side effects afterwards." The patient reported "I was not normal for a full week", reporting that she experienced vomiting, migraines, dizziness, sleeplessness and stroke symptoms. The patient went to the hospital and the patient underwent lab tests and procedures which included magnetic resonance imaging (MRI), Computerised tomogram (CT) scan, and Electroencephalogram (EEG), for which all came back negative and she was discharged after 7 hours. The patient reported that she spoke with her health care professional (HCP) who advised her to go to the emergency room (ER) when she reported having unilateral numbness. The patient reported: left side numbness to her face, fingers, toes, and calf. The patient also reported experiencing dizziness to the point that she couldn't turn around or lean over for 4-5 days. The patient reported that the symptoms started to improve 7 days later, however, she was now apprehensive about getting the second dose.  The patient reported that her doctor said it was fine to get the second dose, but she asked if there was any additional guidance. The patient had spoken to many friends who only experienced a sore arm. On 22Apr2021, the patient woke up with a headache and threw up. The clinical outcome of the events: stroke symptoms, vomiting, migraine, dizziness, sleeplessness, unilateral numbness; left side numbness to her face, fingers, toes, and calf, was recovering. The clinical outcome of the event, headache, was unknown.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head normal, Nausea, Pain in extremity, Paraesthesia, Peripheral swelling
Clinical narrative: stroke symptoms; vomiting; migraine; dizziness; sleeplessness; unilateral numbness; left side numbness to her face, fingers, toes, and calf; headache; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on 30Mar2021 (Batch/Lot Number: ER8737; Expiration Date: Jul2021) as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced stroke symptoms (hospitalization, medically significant), vomiting (hospitalization), migraine (hospitalization), dizziness (hospitalization), sleeplessness (hospitalization), unilateral numbness; left side numbness to her face, fingers, toes, and calf (non-serious). On 22Apr2021, the patient experienced headache (non-serious). The clinical course was reported as follows: The patient asked if she should get the second vaccine dose after her severe side effects. The patient reported that she received her first vaccine dose on 30Mar2021 (Lot number ER8737, exp Jul2021) and experienced "pretty bad side effects afterwards." The patient reported "I was not normal for a full week", reporting that she experienced vomiting, migraines, dizziness, sleeplessness and stroke symptoms. The patient went to the hospital and the patient underwent lab tests and procedures which included magnetic resonance imaging (MRI), Computerised tomogram (CT) scan, and Electroencephalogram (EEG), for which all came back negative and she was discharged after 7 hours. The patient reported that she spoke with her health care professional (HCP) who advised her to go to the emergency room (ER) when she reported having unilateral numbness. The patient reported: left side numbness to her face, fingers, toes, and calf. The patient also reported experiencing dizziness to the point that she couldn't turn around or lean over for 4-5 days. The patient reported that the symptoms started to improve 7 days later, however, she was now apprehensive about getting the second dose.  The patient reported that her doctor said it was fine to get the second dose, but she asked if there was any additional guidance. The patient had spoken to many friends who only experienced a sore arm. On 22Apr2021, the patient woke up with a headache and threw up. The clinical outcome of the events: stroke symptoms, vomiting, migraine, dizziness, sleeplessness, unilateral numbness; left side numbness to her face, fingers, toes, and calf, was recovering. The clinical outcome of the event, headache, was unknown.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: stroke symptoms; vomiting; migraine; dizziness; sleeplessness; unilateral numbness; left side numbness to her face, fingers, toes, and calf; headache; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on 30Mar2021 (Batch/Lot Number: ER8737; Expiration Date: Jul2021) as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced stroke symptoms (hospitalization, medically significant), vomiting (hospitalization), migraine (hospitalization), dizziness (hospitalization), sleeplessness (hospitalization), unilateral numbness; left side numbness to her face, fingers, toes, and calf (non-serious). On 22Apr2021, the patient experienced headache (non-serious). The clinical course was reported as follows: The patient asked if she should get the second vaccine dose after her severe side effects. The patient reported that she received her first vaccine dose on 30Mar2021 (Lot number ER8737, exp Jul2021) and experienced "pretty bad side effects afterwards." The patient reported "I was not normal for a full week", reporting that she experienced vomiting, migraines, dizziness, sleeplessness and stroke symptoms. The patient went to the hospital and the patient underwent lab tests and procedures which included magnetic resonance imaging (MRI), Computerised tomogram (CT) scan, and Electroencephalogram (EEG), for which all came back negative and she was discharged after 7 hours. The patient reported that she spoke with her health care professional (HCP) who advised her to go to the emergency room (ER) when she reported having unilateral numbness. The patient reported: left side numbness to her face, fingers, toes, and calf. The patient also reported experiencing dizziness to the point that she couldn't turn around or lean over for 4-5 days. The patient reported that the symptoms started to improve 7 days later, however, she was now apprehensive about getting the second dose.  The patient reported that her doctor said it was fine to get the second dose, but she asked if there was any additional guidance. The patient had spoken to many friends who only experienced a sore arm. On 22Apr2021, the patient woke up with a headache and threw up. The clinical outcome of the events: stroke symptoms, vomiting, migraine, dizziness, sleeplessness, unilateral numbness; left side numbness to her face, fingers, toes, and calf, was recovering. The clinical outcome of the event, headache, was unknown.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Computerised tomogram, Dizziness, Electroencephalogram, Headache
Clinical narrative: stroke symptoms; vomiting; migraine; dizziness; sleeplessness; unilateral numbness; left side numbness to her face, fingers, toes, and calf; headache; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on 30Mar2021 (Batch/Lot Number: ER8737; Expiration Date: Jul2021) as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced stroke symptoms (hospitalization, medically significant), vomiting (hospitalization), migraine (hospitalization), dizziness (hospitalization), sleeplessness (hospitalization), unilateral numbness; left side numbness to her face, fingers, toes, and calf (non-serious). On 22Apr2021, the patient experienced headache (non-serious). The clinical course was reported as follows: The patient asked if she should get the second vaccine dose after her severe side effects. The patient reported that she received her first vaccine dose on 30Mar2021 (Lot number ER8737, exp Jul2021) and experienced "pretty bad side effects afterwards." The patient reported "I was not normal for a full week", reporting that she experienced vomiting, migraines, dizziness, sleeplessness and stroke symptoms. The patient went to the hospital and the patient underwent lab tests and procedures which included magnetic resonance imaging (MRI), Computerised tomogram (CT) scan, and Electroencephalogram (EEG), for which all came back negative and she was discharged after 7 hours. The patient reported that she spoke with her health care professional (HCP) who advised her to go to the emergency room (ER) when she reported having unilateral numbness. The patient reported: left side numbness to her face, fingers, toes, and calf. The patient also reported experiencing dizziness to the point that she couldn't turn around or lean over for 4-5 days. The patient reported that the symptoms started to improve 7 days later, however, she was now apprehensive about getting the second dose.  The patient reported that her doctor said it was fine to get the second dose, but she asked if there was any additional guidance. The patient had spoken to many friends who only experienced a sore arm. On 22Apr2021, the patient woke up with a headache and threw up. The clinical outcome of the events: stroke symptoms, vomiting, migraine, dizziness, sleeplessness, unilateral numbness; left side numbness to her face, fingers, toes, and calf, was recovering. The clinical outcome of the event, headache, was unknown.